Captor Capital Corp Stock Canadian Securities Exchange
Equities
CA14075H1038
Pharmaceuticals
Sales 2022 | 32.74M 24.04M | Sales 2023 | 41.84M 30.72M | Capitalization | 20.84M 15.3M |
---|---|---|---|---|---|
Net income 2022 | -14M -10.28M | Net income 2023 | -13M -9.54M | EV / Sales 2022 | 0.61 x |
Net cash position 2022 | 13.83M 10.16M | Net cash position 2023 | 10.67M 7.83M | EV / Sales 2023 | 0.24 x |
P/E ratio 2022 |
-2.32
x | P/E ratio 2023 |
-1.6
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.27% |
Managers | Title | Age | Since |
---|---|---|---|
John Zorbas
CEO | Chief Executive Officer | 53 | 17-12-31 |
Jing Peng
DFI | Director of Finance/CFO | 47 | 14-02-28 |
Gavin Davidson
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Klein
BRD | Director/Board Member | 50 | 19-11-20 |
Kyle Appleby
BRD | Director/Board Member | 48 | 14-06-30 |
John Zorbas
CEO | Chief Executive Officer | 53 | 17-12-31 |
1st Jan change | Capi. | |
---|---|---|
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |